Impact of exclusive enteral nutrition on body composition and circulating micronutrients in plasma and erythrocytes of children with active Crohn's disease

Inflammatory Bowel Diseases

Volumn 18, Issue 9, 2012, Pages 1672-1681

  Gerasimidis, Konstantinos ^a   Talwar, Dinesh ^b   Duncan, Andrew ^b   Moyes, Pamela ^b   Buchanan, Elaine ^c   Hassan, Kamal ^c   O'Reilly, Denis ^b   McGrogan, Paraic ^c   Ann Edwards, Christine ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

body composition; Crohn's disease; enteral nutrition; micronutrients

Indexed keywords

ASCORBIC ACID; CAROTENOID; FOLIC ACID; PYRIDOXINE; TRACE ELEMENT;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; CHILD; CLINICAL ARTICLE; CROHN DISEASE; DISEASE MARKER; ENTERIC FEEDING; ERYTHROCYTE; FEMALE; HUMAN; LEAN BODY WEIGHT; MALE; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ANTHROPOMETRY; BIOLOGICAL MARKERS; BODY COMPOSITION; CHILD; CROHN DISEASE; ENTERAL NUTRITION; ERYTHROCYTES; FEMALE; HUMANS; MALE; MICRONUTRIENTS; REMISSION INDUCTION;

EID: 84865027026     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21916     Document Type: Article

References (48)

1. Shanahan F,. Crohn's disease. Lancet. 2002; 359: 62-69.
2. Sawczenko A, Sandhu BK, Logan RF, et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet. 2001; 357: 1093-1094.
3. Levine A, Milo T, Buller H, et al. Consensus and controversy in the management of pediatric Crohn disease: an international survey. J Pediatr Gastroenterol Nutr. 2003; 36: 464-469.
4. Buchanan E, Gaunt WW, Cardigan T, et al. The use of exclusive enteral nutrition for induction of remission in children with Crohn's disease demonstrates that disease phenotype does not influence clinical remission. Aliment Pharmacol Ther. 2009; 30: 501-507.
5. Griffin IJ, Kim SC, Hicks PD, et al. Zinc metabolism in adolescents with Crohn's disease. Pediatr Res. 2004; 56: 235-239.
6. Semrin G, Fishman DS, Bousvaros A, et al. Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis. 2006; 12: 1101-1106.
7. Lih-Brody L, Powell SR, Collier KP, et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci. 1996; 41: 2078-2086.
8. Gerasimidis K, McGrogan P, Edwards CA,. The aetiology and impact of malnutrition in paediatric inflammatory bowel disease. J Hum Nutr Diet. 2011; 24: 313-326.
9. Abad-Lacruz A, Fernandez-Banares F, Cabre E, et al. The effect of total enteral tube feeding on the vitamin status of malnourished patients with inflammatory bowel disease. Int J Vitam Nutr Res. 1988; 58: 428-435.
10. Gray A, McMillan DC, Wilson C, et al. The relationship between the acute changes in the systemic inflammatory response, lipid soluble antioxidant vitamins and lipid peroxidation following elective knee arthroplasty. Clin Nutr. 2005; 24: 746-750.
11. McMillan DC, Sattar N, Talwar D, et al. Changes in micronutrient concentrations following anti-inflammatory treatment in patients with gastrointestinal cancer. Nutrition. 2000; 16: 425-428.
12. Department of Health. Dietary Reference Values for Food Energy and Nutrient for the United Kingdom. Report on Health and Social Subjects No. 41. 1991.
13. Talwar D, Ha TK, Cooney J, et al. A routine method for the simultaneous measurement of retinol, alpha-tocopherol and five carotenoids in human plasma by reverse phase HPLC. Clin Chim Acta. 1998; 270: 85-100.
14. Talwar D, Davidson H, Cooney J, et al. Vitamin B(1) status assessed by direct measurement of thiamin pyrophosphate in erythrocytes or whole blood by HPLC: comparison with erythrocyte transketolase activation assay. Clin Chem. 2000; 46: 704-710.
15. Speek AJ, van SF, Schrijver J, et al. Determination of the B2 vitamer flavin€"adenine dinucleotide in whole blood by high-performance liquid chromatography with fluorometric detection. J Chromatogr. 1982; 228: 311-316.
16. Talwar D, Quasim T, McMillan DC, et al. Optimisation and validation of a sensitive high-performance liquid chromatography assay for routine measurement of pyridoxal 5-phosphate in human plasma and red cells using pre-column semicarbazide derivatisation. J Chromatogr B Analyt Technol Biomed Life Sci. 2003; 792: 333-343.
17. Margolis SA, Davis TP,. Stabilization of ascorbic acid in human plasma, and its liquid-chromatographic measurement. Clin Chem. 1988; 34: 2217-2223.
18. Cole TJ,. Growth charts for both cross-sectional and longitudinal data. Stat Med. 1994; 13: 2477-2492.
19. McCarthy HD, Cole TJ, Fry T, et al. Body fat reference curves for children. Int J Obes (Lond). 2006; 30: 598-602.
20. Wright CM, Sherriff A, Ward SC, et al. Development of bioelectrical impedance-derived indices of fat and fat-free mass for assessment of nutritional status in childhood. Eur J Clin Nutr. 2008; 62: 210-217.
21. Heuschkel RB, Menache CC, Megerian JT, et al. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr. 2000; 31: 8-15.
22. Boot AM, Bouquet J, Krenning EP, et al. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut. 1998; 42: 188-194.
23. Burnham JM, Shults J, Semeao E, et al. Body-composition alterations consistent with cachexia in children and young adults with Crohn disease. Am J Clin Nutr. 2005; 82: 413-420.
24. Akobeng AK, Richmond K, Miller V, et al. Effect of exclusive enteral nutritional treatment on plasma antioxidant concentrations in childhood Crohn's disease. Clin Nutr. 2007; 26: 51-56.
25. Phylactos AC, Fasoula IN, Arnaud-Battandier F, et al. Effect of enteral nutrition on antioxidant enzyme systems and inflammation in paediatric Crohn's disease. Acta Paediatr. 2001; 90: 883-888.
26. Azcue M, Rashid M, Griffiths A, et al. Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone. Gut. 1997; 41: 203-208.
27. Hannon TS, Dimeglio LA, Pfefferkorn MD, et al. Acute effects of enteral nutrition on protein turnover in adolescents with Crohn disease. Pediatr Res. 2007; 61: 356-360.
28. Fernandez-Banares F, bad-Lacruz A, Xiol X, et al. Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol. 1989; 84: 744-748.
29. Kuroki F, Iida M, Tominaga M, et al. Multiple vitamin status in Crohn's disease. Correlation with disease activity. Dig Dis Sci. 1993; 38: 1614-1618.
30. Myung SJ, Yang SK, Jung HY, et al. Zinc deficiency manifested by dermatitis and visual dysfunction in a patient with Crohn's disease. J Gastroenterol. 1998; 33: 876-879.
31. Sandstead HH, Howard L,. Zinc deficiency in Crohn's disease. Nutr Rev. 1982; 40: 109-112.
32. Geerling BJ, Badart-Smook A, Stockbrugger RW, et al. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr. 2000; 54: 514-521.
33. Saibeni S, Cattaneo M, Vecchi M, et al. Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants. Am J Gastroenterol. 2003; 98: 112-117.
34. Bousvaros A, Zurakowski D, Duggan C, et al. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Pediatr Gastroenterol Nutr. 1998; 26: 129-135.
35. Hoffenberg EJ, Deutsch J, Smith S, et al. Circulating antioxidant concentrations in children with inflammatory bowel disease. Am J Clin Nutr. 1997; 65: 1482-1488.
36. Levy E, Rizwan Y, Thibault L, et al. Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease. Am J Clin Nutr. 2000; 71: 807-815.
37. Ojuawo A, Keith L,. The serum concentrations of zinc, copper and selenium in children with inflammatory bowel disease. Cent Afr J Med. 2002; 48: 116-119.
38. Thomas AG, Miller V, Shenkin A, et al. Selenium and glutathione peroxidase status in paediatric health and gastrointestinal disease. J Pediatr Gastroenterol Nutr. 1994; 19: 213-219.
39. Aghdassi E, Wendland BE, Steinhart AH, et al. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. a randomized controlled trial. Am J Gastroenterol. 2003; 98: 348-353.
40. Hengstermann S, Valentini L, Schaper L, et al. Altered status of antioxidant vitamins and fatty acids in patients with inactive inflammatory bowel disease. Clin Nutr. 2008; 27: 571-578.
41. Wendland BE, Aghdassi E, Tam C, et al. Lipid peroxidation and plasma antioxidant micronutrients in Crohn disease. Am J Clin Nutr. 2001; 74: 259-264.
42. Sousa GC, Cravo M, Costa AR, et al. A comprehensive approach to evaluate nutritional status in Crohn's patients in the era of biologic therapy: a case-control study. Am J Gastroenterol. 2007; 102: 2551-2556.
43. Thomas AG, Taylor F, Miller V,. Dietary intake and nutritional treatment in childhood Crohn's disease. J Pediatr Gastroenterol Nutr. 1993; 17: 75-81.
44. Galloway P, McMillan DC, Sattar N,. Effect of the inflammatory response on trace element and vitamin status. Ann Clin Biochem. 2000; 37 (Pt 3): 289-297.
45. Gray A, McMillan DC, Wilson C, et al. The relationship between plasma and red cell concentrations of vitamins thiamine diphosphate, flavin adenine dinucleotide and pyridoxal 5-phosphate following elective knee arthroplasty. Clin Nutr. 2004; 23: 1080-1083.
46. Revel-Vilk S, Tamary H, Broide E, et al. Serum transferrin receptor in children and adolescents with inflammatory bowel disease. Eur J Pediatr. 2000; 159: 585-589.
47. Sentongo TA, Semaeo EJ, Stettler N, et al. Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr. 2002; 76: 1077-1081.
48. Priemel M, von DC, Klatte TO, et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res. 2010; 25: 305-312.